List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

Menten AI Company

Menten AI designs new protein drugs and enzymes using quantum computers and machine learning. Proteins are large molecules that can twist into many shapes. Discovering the right shape for a protein to be a drug or a biocatalyst among almost endless possibilities is a major challenge. Menten AI solves this problem by using machine learning and quantum computing to find better starting points for discovery and further development. Quantum computing makes it possible to represent multiple states of the protein simultaneously and efficiently find the best designs. The team created the world’s first peptide designed on a quantum computer and is now working on peptide therapeutics for oncology and neurodegeneration, as well as on enzymes for industrial applications.

Founded Date: 2018-08-24
Industry: Medicine and Biology
Headquarters: Palo Alto,California,United States,North America
Employee Number: 1-10
Funding Status: private
Super Industry: Quantum Science Applications
Funding Stage: Seed
Funding Total Value: 4005000
Founders: Hans Melo,Tamas Gorbe,Vikram K. Mulligan
Categories: Artificial Intelligence (AI),Biotechnology,Chemical,Health Care,Life Science,Machine Learning,Pharmaceutical,Quantum Computing,Therapeutics
City: Palo Alto
Region: California
Country: United States